Who Really Makes BAM THC?

_{Filed Under: Celebrity Hemp Machine}

---

Brandon “Bam” Margera is selling hemp-derived THC under weed’s cultural shadow.

Celebrity branding gets the first click. The paperwork is where the real story starts.

BAM THC borrows the posture of cannabis culture while placing itself in the hemp-derived market, a legal lane that can easily blur with state-regulated marijuana in the eyes of ordinary consumers. The branding leans on smoke-session cues, flower language, pre-roll talk, and Margera’s public name. The paperwork points to a more complicated product chain.

Pot Culture Magazine followed the chain behind the label: the brand language, the lab reports, the company records, the SMAK’D connection, and the regulatory history around related Smak’D-labeled products.

The central question is simple. Can a buyer clearly understand what is being sold, who makes it, who tests it, and which company is responsible when something goes wrong?

BAM THC’s public presentation borrows heavily from weed culture. Its materials refer to smoke sessions, flower, pre-rolls, concentrates, edibles, and the broader language of cannabis use. To a casual consumer, that can sound like dispensary weed.

The legal footing points somewhere narrower. BAM THC places itself in the hemp-derived lane, built around the current federal hemp framework and products represented as containing no more than 0.3 percent Delta-9 THC by dry weight. As of publication, federal law defines hemp by a Delta-9 THC concentration of not more than 0.3 percent on a dry weight basis.

That distinction is the business model.

Hemp and marijuana come from the same plant species, but American law separates them by Delta-9 THC concentration. The hemp market has used that split to build intoxicating products around Delta-8, hemp-derived Delta-9 edibles, THCA flower, concentrates, and other cannabinoid workarounds. Many of these products can be intoxicating or smokable. Some can feel close enough to weed for ordinary consumers to blur the line. The resemblance does not erase the consumer-protection gap between a state-regulated marijuana product and a hemp-derived product sold online.

FDA says the 2018 Farm Bill removed qualifying hemp from the Controlled Substances Act, but preserved FDA authority over cannabis-derived products under the Federal Food, Drug, and Cosmetic Act.

Based on the public-facing materials reviewed by PCM, BAM THC appears to operate in that hemp-derived commercial lane: a hemp-derived THC brand using the language, posture, and cultural signals of weed.

Hemp-derived does not mean fake. It means clarity matters.

A consumer should not have to decode Farm Bill math, cannabinoid conversions, retailer copy, brand language, and lab reports just to understand what is being sold. When a company borrows weed culture to sell hemp-derived THC, the burden should fall on the company to explain the chain before the famous name does the selling.

The official consumer storefront presents one version of the business. The wider paper trail points to a broader universe through brand language, outside marketplace listings, and third-party lab reports.

That split does not automatically show misconduct. It shows a public-facing structure that is harder to follow than it should be.

---

---

A buyer should not have to guess whether the storefront reflects the whole operation.

BAM THC’s own language points behind Margera and toward SMAK’D. The brand describes the operation as powered by the SMAK’D crew. SMAK’D presents itself as the team behind BAM THC and the foundation behind BAM THC. The clearest brand framing says the products come from SMAK’D, while the public energy comes from Margera.

That is the map the company gives consumers. The same map quickly starts to blur.

The available record points to a hemp brand built around Margera’s public identity and supported by an existing product network. Margera is the public face presented to shoppers. SMAK’D is the product story presented on the brand pages. Terp Nation, USA Hemp Solutions, BakeBoxx, outside retailers, and third-party lab reports appear in the paper trail.

The accountability chain is scattered.

SMAK’D is central because BAM THC makes it central. Yet the public-facing materials reviewed by PCM do not clearly disclose a standalone SMAK’D legal entity, ownership structure, full manufacturing chain, or product-by-product responsibility map. Consumers are left piecing together company relationships through site copy, lab reports, Florida filings, wholesale pathways, and marketplace listings.

One documented corporate trail leads to Terp Nation.

A BAM THC pre-roll lab report reviewed by PCM lists Terp Nation LLC as the client and manufacturer. Florida Division of Corporations records list Terp Nation LLC as an active Florida company filed in 2017, with Jhayson Alvarado and Scot Greve listed as authorized persons. That places Terp Nation inside the BAM THC paper trail, at least for the pre-roll documentation. It does not prove Terp Nation owns the website or controls every product carrying the brand.

Other BAM-branded lab reports point to another manufacturing lane. The Apple Madness gummies report and Blood Orange concentrate report, reviewed by PCM, list the client as “BAM” and list USA Hemp Solutions as the manufacturing facility. That suggests some BAM-branded products use manufacturing separate from the Terp Nation pre-roll trail.

The clean conclusion is narrow: the available record does not show one simple storefront with one obvious production chain. It shows a product network with several names appearing in different parts of the paperwork.

---

---

BakeBoxx also appears around the edges. BAM THC materials reference BakeBoxx and SMAK’D, the site footer credits BakeBoxx as developer, and the wholesale pathway routes toward the BakeBoxx ecosystem. BakeBoxx’s own wholesale language describes a behind-the-scenes supply role dating back to 2017, while its retail presence gives a later founding date. That discrepancy does not prove misconduct. It reinforces the larger point: the public storefront is only one face of a multi-brand, multi-channel operation.

The consumer site does not make the structure plain enough.

A cautious buyer should not have to reverse-engineer the chain through product PDFs, marketplace listings, Florida registry pages, and wholesale breadcrumbs. A serious hemp brand should make the basics easy. Who operates the site? Who owns the product being sold? Who manufactures each category? Which batch lab report matches which listing? Which company handles complaints, refunds, adverse event reports, and regulatory issues?

BAM THC leans heavily on lab-tested language.

In the hemp market, lab reports are usually called Certificates of Analysis, or COAs. A COA is supposed to show what is actually in the product. A useful one should match the exact product and batch number, not just the brand name. It should show potency, cannabinoid profile, and safety screening for pesticides, heavy metals, residual solvents, mold, and other contaminants. Packaging tells the sales story. The COA is supposed to tell the chemistry story.

The official lab-report portal reviewed by PCM showed only two product families: BAM THC Gummies 25mg 15ct and BAM CBD Roll On. Those reports line up with the cleaner consumer storefront, but they do not explain the wider BAM-branded trail visible through outside listings and third-party lab reports.

The lab record cuts both ways.

Several BAM-branded reports appear specific, dated, batch-numbered, and issued by ACS Laboratory. The Apple Madness and Blood Orange reports reviewed by PCM showed passing pesticide and heavy-metal panels. The Rail Runtz report accessible to PCM showed potency data, but not the same full contaminant panel as that visible on the other reviewed reports. That proves documentation exists, but not that the public-facing lab trail is complete.

Consistency remains the problem.

One outside listing reviewed by PCM marketed a BAM-branded concentrate as a THC product involving Delta-8, CBN, and THCP. The corresponding Blood Orange lab report showed the material was predominantly CBD by percentage, with Delta-8 THC also present. A cannabinoid product can contain multiple compounds and may still be lawful depending on formulation and jurisdiction, but a consumer should not have to discover a material discrepancy between retailer copy and a lab PDF after the fact.

The wider edible trail raises a similar clarity issue. An outside listing reviewed by PCM describes BAMTHC 15,000 mg gummies as 1,000 mg per piece with Delta-8, CBN, and THCP. The Apple Madness lab report reviewed by PCM showed a different alt-cannabinoid profile from the lower-dose hemp-derived Delta-9 gummies presented through the official storefront. Those are not the same product class. Shared branding makes precision essential.

A customer should not have to compare separate storefronts, outside retailers, and lab sheets just to understand what kind of cannabinoid product sits behind the same celebrity brand.

The company’s public terms add to the transparency problem.

BAM THC’s refund policy says all sales are final, no returns or exchanges are accepted, and refunds may be considered only for materially defective or clearly spoiled goods. Refund requests cannot be submitted until four weeks after purchase and must be made no later than eight weeks, with approval left to the company’s discretion.

A restrictive refund policy does not make a company illegitimate. Hemp products are difficult to return, and age-restricted commerce creates real compliance burdens. Limited customer recourse still raises the standard for pre-purchase transparency. When a buyer has little room to unwind a purchase, product identity and documentation need to be clean before checkout.

The regulatory history around Smak’d-labeled products is relevant, but the boundaries matter.

On April 17, 2025, the FDA issued a Warning Letter MARCS-CMS 696557 to TKO Distribution LLC, addressed to Jhayson Alvarado. FDA said it reviewed tkodistro.com in March 2025 and found human food products represented as containing Delta-8 THC. The letter specifically named Trippy Smak’d Fuk’d Blend Watermelon 1500 mg Gummies, Trippy Smak’d Fuk’d Blend Pineapple 1500 mg Gummies, and Trippy Smak’d Fuk’d Blend Grape 1500 mg Gummies.The

FDA determined those products were adulterated under federal food law because they bore or contained an unsafe food additive. The agency said that Delta-8 THC added to conventional food is a food additive, is not approved for that use, and does not satisfy GRAS criteria based on the FDA’s review. The

FDA did not issue that warning letter to BAM THC. The letter did not make findings about current BAM THC products. It did not accuse Brandon “Bam” Margera of violating federal law. It did not establish that anything currently sold as BAM THC is unsafe, mislabeled, unlawful, or tied to the exact products named in the letter.

The documented connection is narrower. Smak’d-labeled gummies appeared in an FDA warning letter to TKO Distribution. Florida corporate records show TKO Distribution LLC and Terp Nation LLC with overlapping authorized persons. BAM THC identifies SMAK’D as the product foundation behind the brand. That makes the FDA letter a fair consumer context. It does not make it proof of current BAM THC misconduct.

Celebrity branding changes how trust works.

Brandon “Bam” Margera brings instant recognition. His name carries skate culture, television fame, loyal fans, critics, curiosity, and a public comeback narrative now being used around hemp products. A known face can make a purchase feel personal before the paperwork has earned that feeling.

Cannabis culture has seen the pattern for years. Famous names land on jars, gummies, papers, vapes, drinks, and wellness lines. At times, the celebrity is deeply involved. In other cases, the arrangement is a licensing deal. Often, an operator builds the line while the public face sells the emotion. Those models can be legal. They can also leave consumers unclear about who is actually responsible.

Only transparency separates a serious brand from a costume.

The weakness here is disclosure quality.

The consumer-facing site does not clearly state the full legal operating structure. The catalog is split between the official storefront, broader brand language, outside marketplace listings, and third-party lab reports. The public lab-report portal does not appear to cover the full brand universe. Some descriptions and lab reports do not line up neatly. Refund rules leave customers with limited leverage.

None of that proves fraud. None of it proves danger. The record supports a more measured conclusion: BAM THC has enough documentation to show activity behind the label, but not enough public clarity to meet the standard serious hemp companies should meet.

A cautious buyer should verify the exact product, exact batch, exact cannabinoid profile, exact lab report, and shipping legality before ordering. The burden should not fall that heavily on the customer, but BAM THC’s current available record puts too much of that work on the buyer.

Pot Culture Magazine contacted TKO Distribution LLC through the contact information listed in FDA Warning Letter MARCS-CMS 696557, seeking clarification on its relationship, if any, with SMAK’D and BAM THC, the current status of products named in the warning letter, current product relationships, and lab report availability. PCM also contacted BAM THC through its public contact channel seeking comment on the company’s legal structure, SMAK’D’s role, manufacturing, lab report availability, related entities, and product accountability. PCM contacted Margera through his public Instagram account seeking the proper contact channel for a formal request for comment. Responses were requested by May 18, 2026, at 12:00 PM Central Time. No response had been received by publication time.

A response could have clarified much of the record. TKO could have said whether the products named in the FDA letter were discontinued, reformulated, relabeled, or removed from sale. BAM THC could have explained whether TKO, Terp Nation, USA Hemp Solutions, BakeBoxx, or any related entities currently handle formulation, manufacturing, packaging, distribution, fulfillment, or testing. SMAK’D could have clarified whether it is a manufacturer, product partner, brand family, supplier, or some combination of those roles.

Without those answers, the available record stands on its own.

BAM THC’s public identity runs through Brandon “Bam” Margera. Its product story runs through SMAK’D. Its paper trail reaches Terp Nation, USA Hemp Solutions, BakeBoxx, outside retailers, third-party lab reports, and FDA warning-letter history involving Smak’d-labeled products tied to TKO Distribution.

The record does not prove current wrongdoing.

It proves something more useful to consumers: the available record is too scattered for a brand asking buyers to trust a famous name.

Trust is not built by noise. It is built by records, testing, accountability, and clear answers when consumers ask who stands behind the label.

Celebrity branding can sell the first click. Documentation has to carry the second.

---

_{^{©2026 Pot Culture Magazine. All rights reserved. This content is the exclusive property of Pot Culture Magazine and may not be reproduced, distributed, or transmitted in any form or by any means without prior written permission from the publisher, except for brief quotations in critical reviews.}}

---